MedPath

To Study The Effect of Panchaprasrutik Basti(Medicated Enema) in Patients having Sandhigata Vata specially for Janusandhi(Knee Osteoarthritis).

Phase 2
Not yet recruiting
Conditions
Bilateral primary osteoarthritis of knee. Ayurveda Condition: SANDHIGATAVATAH,
Registration Number
CTRI/2020/12/029741
Lead Sponsor
Dr Krupali Panchal
Brief Summary

Study the efficacy of Panchaprasrutik basti which is medicated decoction will be given as enema through anal route on 76 patients suffernig from Sandhigata vata (Osteoarthritis) of Janusandhi (knee joint). Purpose of this treatment is to nourish and stregthen thr knee joint.

total 76 patients will be given basti for 9days. Total duration of the study is 18days (0, 9, 18days followup)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

Patients having symptoms like Vatapurna druti sparsh(Joint crepitus), Sandhishoola(Joint pain), Sandhishotha(Joint swelling), Aakunchanprasaranjanya Vedana(Joint restriction).

Exclusion Criteria
  • Patients having pther diseases like rheumatoid arthritis, gout, tubarcular knee joint.
  • Patients having history of fracture of knee joint, knee transplantation, psoriatic arthritis or any surgical history of knee joint.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Panchaprasrutik basti is effective in the management of Sandhigatavata with special reference to Janusandhi18 days study with 2 follow up (0,9,18 days)
Secondary Outcome Measures
NameTimeMethod
Reduction in grades of sandhigatavata will be studied18 days study with 2 follow up (0,9,18 days)

Trial Locations

Locations (1)

Dr D Y Patil Ayurved Hospital

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil Ayurved Hospital
🇮🇳Pune, MAHARASHTRA, India
Dr Krupali Panchal
Principal investigator
8380082004
krupalidpanchal@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.